Xeris Biopharma Holdings Inc (NASDAQ:XERS) currently has a daily average trading volume of 1.50M but it saw 1845171 shares traded in last market. With a market cap of 482.76M USD, the company’s current market price of $3.24 came rising about 4.18 while comparing to the previous closing price of $3.11. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.26 and as low as $1.46. In the recent trading on the day, stock has struck highest price mark of $3.08 while lowest mark touched by it was $3.27.
Taking a look at 20-day trading activity of Xeris Biopharma Holdings Inc (XERS) gives us an average price of $2.96, while its current price level is -0.61% below from 52-week high level whereas it is 121.92% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.85 while that of 200 days or SMA-200 reads an average of $2.44. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.31% during that period while stretching the period over a month that increases to 4.44%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 70.38 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Oppenheimer which initiated the stock as “Outperform” in its note to investors issued on March 28, 2024, recommending a price target of $5 for it. Jefferies also issued its recommendations for the stock as it initiated the price target for the stock is $4.
Over the week, XERS’s stock price is moving 6.58% up while it is 15.71% when we observe its performance for the past one month. Year-to-date it is 37.87% up and over the past year, the stock is showing an upside performance of 76.09%.
Currently, Xeris Biopharma Holdings Inc’s total number of outstanding shares is 138.13M. Company’s return on investment (ROI) stands at -24.29% and return on equity (ROE) at -617.16%. Stock’s beta reads 1.85. Stock has a price to sale or P/S ratio amounts to 2.66. Its return on asset (ROA) is -18.04% on average.
